Multimodal Prehabilitation in Cancer Surgery

NCT06788834 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2025-08-07

No results posted yet for this study

Summary

The PROPOSE RCT is a two-arm randomized controlled trial that will be conducted to test the efficacy of a personalized, multidisciplinary pre-operative prehabilitation program (preventive prehabilitation) to reduce serious complications and facilitate recovery after surgery in high-risk patients.

The multimodal prehabilitation program is a preoperative intervention that includes exercise training, nutritional therapy and anxiety reduction techniques, with the aim of preventing or mitigating the functional decline brought about by surgery. 400 patients scheduled for elective major abdominal (including urological), thoracic (including breast) or gynecological cancer surgery will be enrolled. They will be randomized (1:1 ratio) and assigned either to the intervention group (Prehabilitation) or to the control group, which will only be treated according to the usual standard of care within the Enhanced Recovery After Surgery (ERAS) pathways.

Conditions

  • Cancer Surgery

Interventions

BEHAVIORAL

Multimodal prehabilitation Program

A tailored intervention will be prescribed if specific physical, nutritional or psychological impairments will be identified during the assessment phase. Based on the data obtained during the multimodal assessment, different domains and levels of care will be prescribed, focusing on exercise training, and/or nutrition optimization, and/or distress-coping techniques. Different combinations of three domains will be utilized to maximize their synergistic anabolic effects. The duration of the program will be set at a minimum of three weeks.

Sponsors & Collaborators

  • Prof. Pasquale Sansone

    collaborator UNKNOWN
  • Prof. Eugenio Garofalo

    collaborator UNKNOWN
  • Prof. Tiziana Bove

    collaborator UNKNOWN
  • Dr. Claudia Brusasco

    collaborator UNKNOWN
  • Prof. Gabriele Baldini

    collaborator UNKNOWN
  • Dr. Nicola Passuello

    collaborator UNKNOWN
  • Dr. Monica Gualtierotti

    collaborator UNKNOWN
  • Prof. Luca Carlo Nespoli

    collaborator UNKNOWN
  • Università Vita-Salute San Raffaele

    lead OTHER

Principal Investigators

  • Marina Pieri, Medical Doctor · IRCCS Ospedale San Raffaele

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-01-30
Primary Completion
2026-08-31
Completion
2026-09-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06788834 on ClinicalTrials.gov